Untangling Amyloid-β, Tau, and Metals in Alzheimer's Disease

被引:343
|
作者
Savelieff, MG
Lee, S
Liu, YZ
Lim, MH [1 ]
机构
[1] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
基金
美国国家科学基金会;
关键词
A-BETA; OXIDATIVE STRESS; STRUCTURAL-CHARACTERIZATION; NEUROFIBRILLARY TANGLES; IN-VIVO; PROTEIN; AGGREGATION; PEPTIDE; BINDING; PHOSPHORYLATION;
D O I
10.1021/cb400080f
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein misfolding and metal ion dyshomeostasis are believed to underlie numerous neurodegenerative diseases, including Alzheimer's disease (AD). The pathological hallmark of AD is accumulation of misfolded amyloid-beta (A beta) peptides and hyperphosphorylated tau (ptau) proteins in the brain. Since AD etiology remains unclear, several hypotheses have emerged to elucidate its pathological pathways. The amyloid cascade hypothesis, a leading hypothesis for AD development, advocates A beta as the principal culprit. Additionally, evidence suggests that tau may contribute to AD pathology. A beta and tau have also been shown to impact each other's pathology either directly or indirectly. Furthermore, metal ion dyshomeostasis is associated with these misfolded proteins. Metal interactions with A beta and tau/ptau also influences their aggregation properties and neurotoxicity. Herein, we present current understanding on the roles of A beta, tau, and metal ions, placing equal emphasis on each of these proposed features, as well as their inter-relationships in AD pathogenesis.
引用
收藏
页码:856 / 865
页数:10
相关论文
共 50 条
  • [21] Mitochondrial dysfunction - the beginning of the end in Alzheimer's disease? Separate and synergistic modes of tau and amyloid-β toxicity
    Eckert, Anne
    Schmitt, Karen
    Goetz, Juergen
    ALZHEIMERS RESEARCH & THERAPY, 2011, 3 (03)
  • [22] Amyloid-β and Phosphorylated Tau are the Key Biomarkers and Predictors of Alzheimer's Disease
    Pradeepkiran, Jangampalli Adi
    Baig, Javaria
    Islam, Md Ariful
    Kshirsagar, Sudhir
    Reddy, Hemachandra
    AGING AND DISEASE, 2025,
  • [23] New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease
    Zhang, Feng
    Zhong, Ru-jia
    Cheng, Cheng
    Li, Song
    Le, Wei-dong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (09) : 1382 - 1389
  • [24] Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease
    Ferrari-Souza, Joao Pedro
    Ferreira, Pamela C. L.
    Bellaver, Bruna
    Tissot, Cecile
    Wang, Yi-Ting
    Leffa, Douglas T.
    Brum, Wagner S.
    Benedet, Andrea L.
    Ashton, Nicholas J.
    De Bastiani, Marco Antonio
    Rocha, Andreia
    Therriault, Joseph
    Lussier, Firoza Z.
    Chamoun, Mira
    Servaes, Stijn
    Bezgin, Gleb
    Kang, Min Su
    Stevenson, Jenna
    Rahmouni, Nesrine
    Pallen, Vanessa
    Poltronetti, Nina Margherita
    Klunk, William E.
    Tudorascu, Dana L.
    Cohen, Ann D.
    Villemagne, Victor L.
    Gauthier, Serge
    Blennow, Kaj
    Zetterberg, Henrik
    Souza, Diogo O.
    Karikari, Thomas K.
    Zimmer, Eduardo R.
    Rosa-Neto, Pedro
    Pascoal, Tharick A.
    MOLECULAR PSYCHIATRY, 2022, 27 (11) : 4781 - 4789
  • [25] Amyloid- Increases Tau by Mediating Sirtuin 3 in Alzheimer's Disease
    Yin, Junxiang
    Han, Pengcheng
    Song, Melissa
    Nielsen, Megan
    Beach, Thomas G.
    Serrano, Geidy E.
    Liang, Winnie S.
    Caselli, Richard J.
    Shi, Jiong
    MOLECULAR NEUROBIOLOGY, 2018, 55 (11) : 8592 - 8601
  • [26] Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease
    Holtta, Mikko
    Hansson, Oskar
    Andreasson, Ulf
    Hertze, Joakim
    Minthon, Lennart
    Nagga, Katarina
    Andreasen, Niels
    Zetterberg, Henrik
    Blennow, Kaj
    PLOS ONE, 2013, 8 (06):
  • [27] Nanoscale structure of amyloid-β plaques in Alzheimer's disease
    Querol-Vilaseca, Marta
    Colom-Cadena, Marti
    Pegueroles, Jordi
    Nunez-Llaves, Raul
    Luque-Cabecerans, Joan
    Munoz-Llahuna, Laia
    Andilla, Jordi
    Belbin, Olivia
    Spires-Jones, Tara L.
    Gelpi, Ellen
    Clarimon, Jordi
    Loza-Alvarez, Pablo
    Fortea, Juan
    Lleo, Alberto
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [28] Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: seeking direction in a tangle of clues
    Majdi, Alireza
    Sadigh-Eteghad, Saeed
    Aghsan, Sepideh Rahigh
    Farajdokht, Fereshteh
    Vatandoust, Seyed Mehdi
    Namvaran, Ali
    Mahmoudi, Javad
    REVIEWS IN THE NEUROSCIENCES, 2020, 31 (04) : 391 - 413
  • [29] Accumulated Amyloid-β Peptide and Hyperphosphorylated Tau Protein: Relationship and Links in Alzheimer's Disease
    Huang, Han-Chang
    Jiang, Zhao-Feng
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (01) : 15 - 27
  • [30] Biochemically-defined pools of amyloid-β in sporadic Alzheimer's disease: correlation with amyloid PET
    Roberts, Blaine R.
    Lind, Monica
    Wagen, Aaron Z.
    Rembach, Alan
    Frugier, Tony
    Li, Qiao-Xin
    Ryan, Timothy M.
    McLean, Catriona A.
    Doecke, James D.
    Rowe, Christopher C.
    Villemagne, Victor L.
    Masters, Colin L.
    BRAIN, 2017, 140 : 1486 - 1498